CRP and androgen insensitivity syndrome: Furthermore, our findings did not suggest any association between the prognosis (mRS > 2) of malignancy-related AIS patients and previously reported clinical parameters including elevated D-dimer (15), CRP (16), and eosinophils (17), or underlying co-morbidities (18).